Headlines about NantKwest (NASDAQ:NK) have been trending somewhat positive recently, Accern Sentiment reports. The research group scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. NantKwest earned a daily sentiment score of 0.07 on Accern’s scale. Accern also gave headlines about the biotechnology company an impact score of 44.0834590255073 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

NantKwest (NASDAQ NK) traded down 1.66% during midday trading on Monday, hitting $5.94. 159,114 shares of the stock were exchanged. The firm has a 50 day moving average of $5.94 and a 200-day moving average of $5.37. NantKwest has a 12-month low of $2.71 and a 12-month high of $9.60. The stock’s market cap is $471.87 million.

A number of equities analysts have commented on the stock. Citigroup Inc. set a $3.00 target price on shares of NantKwest and gave the stock a “sell” rating in a research note on Monday, August 14th. BidaskClub downgraded shares of NantKwest from a “hold” rating to a “sell” rating in a research note on Tuesday, August 8th. Zacks Investment Research downgraded shares of NantKwest from a “buy” rating to a “hold” rating in a research note on Wednesday, July 12th. Finally, ValuEngine raised shares of NantKwest from a “strong sell” rating to a “sell” rating in a research note on Wednesday, June 14th. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company. NantKwest presently has an average rating of “Hold” and a consensus price target of $5.94.

COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect NantKwest (NK) Stock Price” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was stolen and republished in violation of US and international copyright laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/09/18/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-nantkwest-nk-stock-price.html.

In other NantKwest news, Director Steve Gorlin sold 103,841 shares of the firm’s stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $6.04, for a total transaction of $627,199.64. Following the sale, the director now directly owns 375,002 shares of the company’s stock, valued at approximately $2,265,012.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold a total of 183,445 shares of company stock worth $1,173,251 over the last ninety days. 70.19% of the stock is owned by corporate insiders.

NantKwest Company Profile

Insider Buying and Selling by Quarter for NantKwest (NASDAQ:NK)

Receive News & Stock Ratings for NantKwest Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantKwest Inc. and related stocks with our FREE daily email newsletter.